Epidermal and dermal characteristics in skin equivalent after systemic and topical application of skin care ingredients
Language English Country United States Media print
Document type Comparative Study, Journal Article
PubMed
16804008
DOI
10.1196/annals.1354.046
PII: 1067/1/337
Knihovny.cz E-resources
- MeSH
- Ki-67 Antigen metabolism MeSH
- Administration, Topical MeSH
- Cell Culture Techniques MeSH
- Adult MeSH
- Elastin metabolism MeSH
- Epidermal Cells * MeSH
- Fibrillin-1 MeSH
- Fibrillins MeSH
- Filaggrin Proteins MeSH
- Glycosaminoglycans administration & dosage pharmacology MeSH
- Keratinocytes cytology metabolism MeSH
- Kinetin pharmacology MeSH
- Cells, Cultured MeSH
- Skin MeSH
- Drug Interactions MeSH
- Humans MeSH
- Microfilament Proteins metabolism MeSH
- Skin Care * MeSH
- Intermediate Filament Proteins analysis metabolism MeSH
- Proteins administration & dosage pharmacology MeSH
- Plant Growth Regulators pharmacology MeSH
- Dermis cytology MeSH
- Skin, Artificial * MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
- Names of Substances
- Ki-67 Antigen MeSH
- Elastin MeSH
- FBN1 protein, human MeSH Browser
- Fibrillin-1 MeSH
- Fibrillins MeSH
- Filaggrin Proteins MeSH
- FLG protein, human MeSH Browser
- Glycosaminoglycans MeSH
- Imedeen MeSH Browser
- Kinetin MeSH
- Microfilament Proteins MeSH
- Intermediate Filament Proteins MeSH
- Proteins MeSH
- Plant Growth Regulators MeSH
Effects of active ingredients from topical and systemic skincare products on structure and organization of epidermis, dermal-epidermal junction (DEJ), and dermis were examined using an in vitro reconstructed skin equivalent (SE). Imedeen Time Perfection (ITP) ingredients (a mixture of BioMarine Complex, grape seed extract, tomato extract, vitamin C) were supplemented systemically into culture medium. Kinetin, an active ingredient from Imedeen Expression Line Control Serum, was applied topically. Both treatments were tested separately or combined. In epidermis, all treatments stimulated keratinocyte proliferation, showing a significant increase of Ki67-positive keratinocytes (P < 0.05). Kinetin showed a twofold increase of Ki67-positive cells, ITP resulted in a fivefold, and ITP+kinetin showed a nine-fold increase. Differentiation of keratinocytes was influenced only by kinetin since filaggrin was found only in kinetin and kinetin+ITP samples. At the DEJ, laminin 5 was slightly increased by all treatments. In dermis, only ITP increased the amount of collagen type I. Both kinetin and ITP stimulated formation of fibrillin-1 and elastin deposition. The effect of kinetin was seen in upper dermis. It stimulated not only the amount of deposited fibrillin-1 and elastin fibers but also their organization perpendicularly to the DEJ. ITP stimulated formation of fibrillin-1 in deeper dermis. In summary, the combination of topical treatment with kinetin and systemic treatment with ITP had complementary beneficial effects in the formation and development of epidermis and dermis.
References provided by Crossref.org
Photoprotective properties of new derivatives of kinetin